<DOC>
	<DOCNO>NCT02429037</DOCNO>
	<brief_summary>The objective study investigate efficacy safety rAd-p53 gene combine radio- chemo-therapy vs. radio- chemo- therapy treatment unresectable , locally advanced head neck cancer . This phase 2 , open label , active-controlled study .</brief_summary>
	<brief_title>P53 Gene Combined With Radio- Chemo-therapy Treatment Unresectable Locally Advanced Head Neck Cancer</brief_title>
	<detailed_description>To evaluate benefit rAd-p53 ) gene therapy combine radio- chemo-therapy treatment unresectable , locally advanced head neck cancer , total 60 patient condition randomly assign two group : experiment group ( EG ) control group ( CG ) . The EG receive multi-point injection rAd-p53 tumor day 1 , 8 15 dose 2 Ã— 10^12 viral particle ( VP ) 21-days cycle . Both EG CG give radiotherapy total dose 60 Gy chemotherapy ( Cisplatin 100 mg/m2 IV day 1 plus paclitaxel 30 mg/m2 IV day 1 , 8 15 ) . The patient treat disease progression , withdrawal study , untolerated adverse event . study endpoint efficacy ( Progression-free survival , overall survival ) safety variable .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>1. histopathologically diagnose head neck cancer ; 2. unresectable , locally advance ; 3 . 18 year old ; 4. Eastern Cooperative Oncology Group ( ECOG ) score 02 ; 5. normal test hemogram , blood coagulation , liver kidney function ; 6.signed informed consent form . 1 . Serious blood coagulation disorder , bleed tendency , platelet &lt; 6 * 1000000000/L ; 2. serious heart , lung function abnormality severe diabetes patient ; 3. active infection ; 4. severe atherosclerosis ; 5 . AIDS patient ; 6. serious thrombotic embolic event within 6 month ; 7. renal insufficiency require hemodialysis peritoneal dialysis ; 8. pregnant lactate woman ; 9. mental disorder disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>p53</keyword>
	<keyword>gene therapy</keyword>
	<keyword>head neck cancer</keyword>
</DOC>